4//SEC Filing
Shani Eli 4
Accession 0001209191-23-014441
CIK 0000818686other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 7:37 AM ET
Size
7.6 KB
Accession
0001209191-23-014441
Insider Transaction Report
Form 4
Shani Eli
EVP,Global Marketing&Portfolio
Transactions
- Exercise/Conversion
Ordinary Shares
2023-02-28+5,311→ 25,052 total - Exercise/Conversion
Restricted Share Units
2023-02-28−5,311→ 5,312 total→ Ordinary Shares (5,311 underlying)
Footnotes (3)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F3]Restricted share units were granted on February 28, 2020 with 5,311 vested on each of February 28, 2021, February 28, 2022 and February 28, 2023 and 5,312 vesting on February 28, 2024.
Documents
Issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
CIK 0000818686
Entity typeother
Related Parties
1- filerCIK 0001876642
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 7:37 AM ET
- Size
- 7.6 KB